|
Can’t access the links? Add “lnks.gd” to the allowlist of your content blocking software. |
|
|
In 2024, the Washington State Legislature, as noted in Sec. 215 (136) of Engrossed Substitute Senate Bill 5950, approved $1,500,000 of one-time funding for state fiscal year (SFY) 2025 and state fiscal year (SFY) 2026. The funding will establish high-intensity community-based teams serving people with opioid use disorder.
The Health Care Authority (HCA) has budgeted one-time funding not to exceed $3,000,000: $1,500,000 for SFY2025 and $1,500,000 for SFY2026. HCA will enter a contract with the awarded providers no later than the beginning of year 2025. Funding and contract timelines will be determined based on requested and approved funding amounts.
Funding must be used to significantly increase administration of long-acting injectable buprenorphine to people at highest risk for overdose. This funding opportunity is open to:
- Existing field-based programs funded with federal state opioid response grants and their subcontractors
- Low-barrier buprenorphine programs
- Street medicine teams
|
|
|
The informational webinar regarding this funding occurred Wednesday, October 2, at noon. The PowerPoint presentation of this webinar is available now in PDF form.
|
|
|
More information about this program and others can be found regularly updated on the HCA website.
Questions and responses around the High Intensity Community-based Opioid Use Disorder Treatment Teams have been compiled. Further questions or inquiries can be directed to medical programs specialist Cayla Rauh.
|
|
|
|